Suven Life Sciences granted patents – Aims to meet unmet medical needs of cognitive disorders
Drug firm Suven Life Sciences has been granted a patent from Europe and two product patents from Eurasia for a […]
India’s Pharma Exports to Reach Rs 1.1 Lakh Crore by FY16: Ind-Ra
India’s pharma exports are expected to reach Rs 1,10,000 crore by year 2015-16 from Rs 91,000 crore last fiscal, says […]
Real costs of R& D decoded
Recent analysis shows that the high priced research and development companies which show $1.3 billion cost are not real.
Developing nations will lobby for research funds for TB, malaria
India and other developing countries are set to lobby hard for funding mechanisms to develop medicines,
mostly aimed at neglected diseases such as tuberculosis and malaria, at a forum set up by the World Health Organization or WHO. Developed countries have long maintained that patents are sufficient incentive for innovation.
Imported medical devices come under lens
A government committee has decided to widen the ambit of its initial mandate and find ways to control the prices of imported medical devices.
It is a different ball game in the case of patents’ filing in India
It has come to the notice that despite the presence of a patent law that guards against giving exclusive commercial rights for modifications of existing medicines, research firms, both multinational and domestic, have tried their luck on 80 patent applications on TB drugs pending with Indian patent offices across the country.
EU urged for funding generic drug industry
The European Parliament will be demanding for funds to creation of a generic drugs industry in poor countries as the long-term solution to the developing world’s health crisis.
